CAS No 28721-07-5 , 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide Search by region : Canada

Name: 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
Synonyms: Oxcarbazepime; Oxcarbamazepine; Oxcarbazepinum; Epilexter; Timox;Trileptal; Oxcarbazepina;5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide; 28721-07-5; Oxacarbazepine;
CAS Registry Number:28721-07-5
Transport: 20kgs
Flash Point: 230
Boiling Point: 457
Density: 1.329g/cm³
Refractive index: 1.661
Hazard Symbols: UN NO.
Flash Point: 230
EINECS: 249-188-8
Molecular Weight: 252.26798
InchiKey: CTRLABGOLIVAIY-UHFFFAOYSA-N
InChI: InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13
(11)17/h1-8H,9H2,(H2,16,19)
Molecular Formula: C₁₅H₁₂N₂O₂
Molecular Structure:

Related products

Select to

          
           28721-07-5 OXCARBAZEPINE
           
             SynFine Research Inc.
             
              [Manufacturer]
Tel:  905-737-2702
Fax:  905-737-6299
Address: SynFine Research Inc. 
P.O. Box 433 ? Station A 
Richmond Hill, ON L4C 4Y8 
Canada null,nullCanada

           28721-07-5 OXCARBAZEPINE
           
             Synth?se AptoChem Inc.
             
              [Manufacturer]
Tel:  514-496-4252
Fax:  514-496-4253
Address: Synth?se AptoChem Inc.
6100 Royalmount Ave
Montreal, QC
Canada
H4P 2R2 null,nullCanada

           28721-07-5 10,11-DIHYDRO-10-HYDROXYCARBAMAZEPINE
           
             TLC PharmaChem., Inc.
             
              [Manufacturer]
Tel:  905-760-1098
Fax:  905-760-2098
Address: TLC PharmaChem., Inc.
5-150 Connie Crescent
Concord, Ontario
L4K 1L9, Canada null,nullCanada

Select to

1/1

References of 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide

Title: Oxcarbazepine
CAS Registry Number: 28721-07-5
CAS Name: 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
Synonyms: oxacarbazepine
Manufacturers' Codes: GP-47680
Trademarks: Trileptal (Novartis)
Molecular Formula: C15H12N2O2
Molecular Weight: 252.27
Percent Composition: C 71.42%, H 4.79%, N 11.10%, O 12.68%
Literature References: Ketoderivative of carbamazepine, q.v. Prepn: W. Schindler, DE 2011087 (1970 to Geigy); idem, US 3642775 (1972 to Ciba-Geigy). Improved prepn: D. Kaufmann et al., Tetrahedron Lett. 45, 5275 (2004). Metabolism: H. Schütz et al., Xenobiotica 16, 769 (1986). Hyponatremic effects: O. A. Nielsen et al., Epilepsy Res. 2, 269 (1988). Determn of oxcarbazepine and main metabolites by GC in plasma: G. E. Von Unruh, W. D. Paar, J. Chromatogr. 345, 67 (1985); by HPLC: A. A. Elyas, V. D. Goldberg, ibid. 528, 473 (1990). Clinical evaluation in treatment of epilepsy: M. Dam et al., Epilepsy Res. 3, 70 (1989); in management of trigeminal neuralgia: J. M. Zakrzewska, P. N. Patsalos, J. Neurol. Neurosurg. Psychiatry 52, 472 (1989). Review of pharmacology and therapeutic efficacy: A. Beydoun, E. Kutluay, Expert Opin. Pharmacother. 3, 59-71 (2001).
Properties: Crystals from ethanol, mp 215-216°.
Melting point: mp 215-216°
Therap-Cat: Anticonvulsant.
Keywords: Anticonvulsant.